Search results for "VACCINATION"

showing 10 items of 660 documents

Influenza vaccination: opinions of health care professionals working in pediatric emergency departments

2018

Abstract Background Vaccine coverage of health care professionals against influenza is still low in Italy, as well as in other European countries. Methods Between March and May 2018, this study was performed to collect the opinions of Pediatric health care professionals, working in emergency departments, regarding the efficacy and safety of the influenza vaccine. An anonymous online survey was employed to evaluate socio-demographic and professional characteristics, knowledges, beliefs and attitudes. Results Five hundred four health care professionals completed the survey: 331 physicians, 140 nurses and 33 other health are professionals. During the 2017–18 season, 55.8% of physicians, 19.3% …

AdultMalePediatric emergencyVaccine coveragemedicine.medical_specialtyInfectious Disease Transmission Patient-to-ProfessionalAttitude of Health PersonnelInfluenza vaccinePediatric healthHealth PersonnelHhealth care professionals; influenza vaccination; Italy; vaccine coverageeducationNursing Staff HospitalHealth care professionalInfectious Disease Transmission Professional-to-PatientYoung Adult03 medical and health sciences0302 clinical medicineSurveys and Questionnaires030225 pediatricsHealth careMedical Staff HospitalHumansMedicine030212 general & internal medicinehealth care economics and organizationsAgedbusiness.industryResearchVaccinationlcsh:RJ1-570lcsh:PediatricsMiddle AgedSettore MED/38humanitiesInfluenza vaccinationHealth care professionalsVaccinationTrustworthinessItalyInfluenza VaccinesFamily medicineFemaleClinical CompetenceEmergency Service HospitalbusinessItalian Journal of Pediatrics
researchProduct

Pharmacoeconomic assessment of implementing a universal PCV-13 vaccination programme in the Valencian public health system (Spain).

2011

Background: Heptavalent pneumococcal conjugate vaccine (PCV-7) was licensed to provide immunity against pneumococcal disease caused by seven serotypes of S. pneumoniae. Thirteen-valent pneumococcal conjugate vaccine (PCV-13) includes 6 additional serotypes for preventing invasive pneumococcal disease. Objective: The objective of this study was to estimate the potential health benefits, costs, and cost-effectiveness of vaccination with PCV-13 in the Community of Valencia and to generate valuable information for policy makers at regional and country levels. Methods: A decision tree was designed to determine the health and economic outcomes in hypothetical cohorts of vaccinated and unvaccinate…

AdultMalePediatricsmedicine.medical_specialtyAdolescentCost effectivenessPharmacoeconomic assessmentCost-Benefit AnalysisPneumococcal conjugate vaccinePneumococcal InfectionsHerd immunityPneumococcal VaccinesIndirect costsYoung AdultEnvironmental healthmedicineHeptavalent Pneumococcal Conjugate VaccineHumansChildAgedAged 80 and overGeneral VeterinaryGeneral Immunology and Microbiologybusiness.industryPneumococcal conjugate vaccineVaccinationPublic Health Environmental and Occupational HealthInfant NewbornInfantMiddle AgedQuality-adjusted life yearVaccinationInfectious DiseasesSpainChild PreschoolCohortMolecular MedicineCost-effectivenessFemalebusinessmedicine.drugVaccine
researchProduct

Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccinatio…

2009

Priming a population with a pre-pandemic vaccine is being considered to maximize the response upon subsequent vaccination with a true pandemic vaccine more closely matched to the causative pandemic strain. The present study explored this prime-boost concept by evaluating different primary schedules with the pre-pandemic A/Vietnam/1194/2004(NIBRG-14) vaccine, containing 3.75 microg of HA, followed by a 6-month booster with a vaccine formulated with 3.75 microg HA of either the same strain or with A/Indonesia/05/2005(IBCDC-RG2), a heterologous strain from a different clade. In this multicentre, open, randomized study (NCT00430521) we measured immune responses in four groups (N = 48-60) of adu…

AdultMalePediatricsmedicine.medical_specialtyAdolescentCross Protectionmedicine.medical_treatmentPopulationImmunization SecondaryBooster doseAntibodies ViralYoung AdultAdjuvants ImmunologicImmunityInfluenza Humanparasitic diseasesmedicineHumansAS03educationeducation.field_of_studyBooster (rocketry)Influenza A Virus H5N1 SubtypeGeneral VeterinaryGeneral Immunology and Microbiologybusiness.industryPublic Health Environmental and Occupational HealthHemagglutination Inhibition TestsMiddle AgedImmunity HumoralVaccinationInfectious DiseasesImmunizationInfluenza VaccinesImmunologyMolecular MedicineFemalebusinessAdjuvantVaccine
researchProduct

The impact of ten years of infant universal Varicella vaccination in Sicily, Italy (2003-2012).

2015

Introduction Universal varicella vaccination in Sicily was introduced in infant population since 2003, with a rapidly increasing coverage. Aim of the present study was to analyze changes in the epidemiology of varicella since the introduction of universal vaccination. Methods The study was performed by analyzing Sicilian administrative/clinical data on varicella case notifications and hospitalizations from 2003 to 2012 (ICD-9-CM discharge diagnosis codes 052 and 052.×). MMR+V and V coverage were also calculated for each birth cohort. Moreover, blood samples drawn in 2013/2014 from general population stratified by age were tested for varicella antibodies. Results From 2003 to 2012, 15 433 va…

AdultMalePediatricsmedicine.medical_specialtyAdolescentImmunologyPopulationSocio-culturalecoverageVaricella vaccinationAntibodies ViralSettore MED/42 - Igiene Generale E ApplicataChickenpox VaccineYoung AdultChickenpoxvaricellaEpidemiologyHumansImmunology and AllergyMedicineYoung adultChildeducationDisease NotificationSicilyChickenpox VaccineHospitalizationsPharmacologyeducation.field_of_studyChickenpoxbusiness.industryVaccinationInfant NewbornInfantNotificationsmedicine.diseaseHospitalizationVaccinationCoverage; Epidemiology; Hospitalizations; Notifications; Sicily; Universal mass vaccination; VaricellaChild PreschoolFemaleepidemiologynotificationbusinessBirth cohortuniversal mass vaccinationHumanResearch Paperhospitalization
researchProduct

Immunity to tetanus in the 3-20 year age group in Italy

1997

In Italy, systematic mandatory tetanus immunization of children started in 1968. In 1989, immunity against tetanus was assessed in a random sample of 758 healthy subjects aged 3-20 y, from four Italian cities. There were 257 subjects 3-5 y old all residing in Southern Italy and 501 subjects 11-20 y old from both the South and North. The overall prevalence of non-immune subjects was 19.1%, without difference by sex. The rates of subjects lacking protective antibody titres was 25.3% in children 3-5 y old (all coming from South and the islands), 11.5% in those 11 y old, and 18.9% in the 18-20 y age-group, respectively. Subjects 11-20 y old residing in the South and the islands were more likely…

AdultMalePediatricsmedicine.medical_specialtyAdolescentTetanus immunizationTetanus.ImmunitymedicinePrevalenceTetanus ToxoidHumansChildHigh rateTetanusTetanusbusiness.industryPublic Health Environmental and Occupational HealthHealthy subjectsImmunityGeneral Medicinemedicine.diseaseAntibodies BacterialVaccinationItalyChild PreschoolFemaleProtective antibodyGeographical inequalitiesbusiness
researchProduct

Optimizing strategies for meningococcal C disease vaccination in Valencia (Spain)

2014

Background: Meningococcal C (MenC) conjugate vaccines have controlled invasive diseases associated with this serogroup in countries where they are included in National Immunization Programs and also in an extensive catch-up program involving subjects up to 20 years of age. Catch-up was important, not only because it prevented disease in adolescents and young adults at risk, but also because it decreased transmission of the bacteria, since it was in this age group where the organism was circulating. Our objective is to develop a new vaccination schedule to achieve maximum seroprotection in these groups. Methods: A recent study has provided detailed age-structured information on the seroprote…

AdultMalePediatricsmedicine.medical_specialtyAdolescentVaccination scheduleMeningococcal VaccinesDiseaseBooster doseMeningococcal vaccineVaccination programsYoung AdultMeningococcal C conjugate vaccinesmedicineHumansYoung adultChildImmunization Programsbusiness.industryIncidence (epidemiology)VaccinationSeroprotection studyMiddle AgedAgent-based modellingMeningococcal InfectionsVaccinationInfectious DiseasesImmunizationSpainChild PreschoolFemaleMATEMATICA APLICADAbusinessResearch ArticleBMC Infectious Diseases
researchProduct

Effectiveness of pandemic and seasonal influenza vaccines in preventing pandemic influenza-associated hospitalization.

2011

Vaccines are leading pharmacological measures for limiting the impact of pandemic influenza in the community. The objective of this study was to investigate the effectiveness of influenza (pandemic and seasonal) vaccines in preventing pandemic influenza-associated hospitalization. We conducted a multicenter matched case-control study in 36 Spanish hospitals. Patients hospitalized with confirmed pandemic influenza between November 2009 and February 2010 and two hospitalized controls per case, matched according to age, date of hospitalization and province of residence, were selected. Multivariate analysis was performed using conditional logistic regression. Subjects were considered vaccinated…

AdultMalePediatricsmedicine.medical_specialtyMultivariate analysisAdolescentSeasonal influenzaYoung AdultPandemicInfluenza HumanMedicineHumansYoung adultChildAgedAged 80 and overGeneral VeterinaryGeneral Immunology and Microbiologybusiness.industryPublic Health Environmental and Occupational HealthPandemic influenzaCase-control studyInfant Newbornvirus diseasesInfantMiddle AgedHospitalsVaccinationHospitalizationInfectious DiseasesInfluenza VaccinesSpainCase-Control StudiesChild PreschoolImmunologyHuman mortality from H5N1Molecular MedicineFemalebusinessVaccine
researchProduct

Obesity and other medical comorbidities among NT1 patients after the Norwegian H1N1 influenza epidemic and vaccination campaign.

2019

Abstract Study Objectives Narcolepsy type 1 (NT1) may be complicated by comorbidities. We aimed to study the extent of obesity and other medical comorbidities in a Norwegian population of NT1 patients with debut of symptoms after the 2009 H1N1 influenza epidemic and vaccination campaign. We also aimed to explore factors associated with obesity. Methods Ninety-one patients (48 children and 43 adults) were included in this cross-sectional study, 80 of whom were H1N1-vaccinated. All participants were hospitalized and underwent sleep investigation and physical examination, and completed a semi-structured clinical interview. Results In children, 16 females (70%) and 10 males (40%) were classifie…

AdultMalePediatricsmedicine.medical_specialtyPopulationPhysical examinationNorwegianComorbidityOverweightInfluenza A Virus H1N1 SubtypePhysiology (medical)Influenza HumanmedicineHumansObesityeducationChildEpidemicsNarcolepsyeducation.field_of_studymedicine.diagnostic_testbusiness.industryImmunization ProgramsNorwaymedicine.diseaseComorbidityObesitylanguage.human_languageVaccinationCross-Sectional StudiesCohortlanguageFemaleNeurology (clinical)medicine.symptombusinessSleep
researchProduct

Immunologic findings in workers formerly exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin and its congeners

1998

One hundred ninety-two workers in a German pesticide factory who were exposed to polychlorinated dibenzodioxins and -furans (PCDD/PCDF) were investigated for former and present diseases and laboratory changes of the immune system. Moreover, in a subgroup of 29 highly exposed and 28 control persons, proliferation studies were performed. In addition to assays such as blood count, immunoglobulins, serum electrophoresis, monoclonal bands, surface markers, autoantibodies, and lymphocyte proliferation, two new methods, the rise of tetanus antibody concentration after vaccination and the in vitro resistance of lymphocytes to chromate, were used to diagnose the morphologic and functional state of t…

AdultMalePolychlorinated DibenzodioxinsHealth Toxicology and MutagenesisPolychlorinated dibenzodioxinsLymphocyte proliferationLymphocyte ActivationCohort Studieschemistry.chemical_compoundImmune systemImmunityOccupational ExposuremedicineChromatesTetanus ToxoidHumansPesticidesPhytohemagglutininsFuransAgedImmunity CellularbiologyTetanusPublic Health Environmental and Occupational HealthAutoantibodyMiddle Agedmedicine.diseaseVaccinationchemistryChemical IndustryImmunologyAntibody Formationbiology.proteinFemaleAntibodyResearch Article
researchProduct

Logistic regression of attitudes and coverage for influenza vaccination among Italian Public Health medical residents

2014

Introduction. A few number of literature specifically addresses vaccination uptake among Public Health Residents (PHRs). Influ- enza vaccine attitudes and risk perceptions of PHRs across Italy were studied, contributing to literature on influenza vaccination uptake predictors, in particular among young physicians. Methods. An online survey was conducted in 25 Schools of Public Health in Italy in 2011-2012. Results were analysed using preva- lence and logistic regression methods. Results. A total of 365 Italian public health residents were included in the study. Vaccination uptake was confirmed by 22.2 and 33.2% of PHRs in 2010-2011 and 2011-2012, respectively. For the 2010-2011 influenza se…

AdultMaleRisk perceptionAttitude of Health PersonnelMedical Residents; Influenza vaccination; Risk perceptionInternship and ResidencySettore MED/42 - Igiene Generale E ApplicataInfluenza vaccinationLogistic ModelsItalyInfluenza VaccinesInfluenza HumanHumansOriginal ArticleMedical ResidentsFemalePublic HealthMedical ResidentJournal of Preventive Medicine and Hygiene
researchProduct